IntroductionThe Olanzapine Market represents a critical segment of the global psychiatric and neurological therapeutics industry, focusing on the treatment of schizophrenia, bipolar disorder, and other mood disorders. Olanzapine, a second-generation atypical antipsychotic, works by balancing dopamine and serotonin levels in the brain, helping to stabilize mood and reduce psychotic symptoms. The increasing prevalence of mental […]